45
Shionogi
4507.T·TSEOsaka JPFounded 18785,500 employees
Mid CappharmaPublicInfectious DiseaseCNS
Platform: Antiviral
Market Cap
$8B
All Drugs
4
Clinical Trials
8
Failed / Terminated
0
FDA Approved
3
Stock Price & Catalysts (4507.T)
Loading 4507.T stock data...
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| 450-6746 | 450-6746 | Approved | 1 | PD-1 | FSGS | ||
| 450-7253 | 450-7253 | Approved | 2 | VEGF | PNH | ||
| Voxanaritide | 450-9936 | Approved | 4 | SGLT2 | AMLNSCLC | ||
| 450-7627 | 450-7627 | Phase 1/2 | 1 | KRASG12C | Schizophrenia |
SEC Filings & Financial Documents
SEC filings are not available for TSE-listed companies.
Shionogi trades on TSE (JP). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (8)